Hôpital Louis Pradel

Bron, Auvergne-Rhône-Alpes 69500

0 studies enrolling now · 3 studies all time

What they study most

Adjuvant, Autoimmune Pulmonary Alveolar Proteinosis, EGFR, Early Stage Lung Cancer, Exon 20, Lung Cancer, NSCLC, Stage IB-IIIA, Patients With Non-Small Cell Lung Cancer, Post-surgical, Uncommon EGFR Mutations

Studies at this site

• Trial of Therapeutic Cancer Vaccine OSE2101 in Patients With Non-Small Cell Lung Cancer and Secondary Resistance to Immune Checkpoint Inhibitor — Recruiting now
• A Study to Assess the Efficacy and Safety of Zipalertinib Versus Placebo for Adjuvant Treatment in Participants With Stage IB-IIIA NSCLC With Uncommon EGFR Mutations, Following Complete Tumor Resection — Running, not enrolling
• Clinical Trial of Inhaled Molgramostim Nebulizer Solution in Autoimmune Pulmonary Alveolar Proteinosis (aPAP) — Running, not enrolling